结构化电话递送干预减少甲基苯丙胺使用:平行组随机对照试验研究方案
本研究为双盲平行组随机对照试验,计划在澳大利亚招募196±8名轻度至中度甲基苯丙胺使用障碍个体,随机分配接受Ready2Change-Methamphetamine(R2C-M)干预(n=98±4;4至6次电话递送干预会话、R2C-M工作簿和甲基苯丙胺信息手册)或对照(n=98±4;4至6次≤5分钟电话问候及含获取进一步支持信息的甲基苯丙胺信息手册)。主要结局为随机化后3个月甲基苯丙胺问题严重程度(DUDIT)的变化。
要点
- 首个评估电话递送干预对甲基苯丙胺使用障碍疗效的国际随机对照试验。
- 主要结局为随机化后3个月DUDIT评分变化,随访至12个月。
- 将进行混合方法项目评估和成本效果分析。
核心结论
- 本研究将是国际上首个评估电话递送干预对甲基苯丙胺使用障碍及相关危害疗效的随机对照试验。
- 所提出的干预有望为原本不太可能寻求治疗的个人提供有效、低成本、可扩展的治疗,预防未来危害并减少卫生服务和社区成本。
研究设计与样本
- 双盲、平行组随机对照试验,计划在澳大利亚招募196±8名轻度至中度甲基苯丙胺使用障碍个体。
- 参与者随机分配至R2C-M干预组(n=98±4;4至6次电话递送干预会话、R2C-M工作簿和甲基苯丙胺信息手册)或对照组(n=98±4;4至6次≤5分钟电话问候及含获取进一步支持信息的甲基苯丙胺信息手册)。
- 电话随访评估在随机化后6周以及3、6和12个月进行。
- 主要结局为随机化后3个月甲基苯丙胺问题严重程度(DUDIT)的变化。
- 将进行混合方法项目评估并考察成本效果。
关键数值与推荐
- 主要结局:随机化后3个月甲基苯丙胺问题严重程度(DUDIT)的变化。
- 次要结局包括:随机化后6和12个月甲基苯丙胺问题严重程度(DUDIT)、甲基苯丙胺使用量、使用天数、符合使用障碍标准数、渴求、心理功能、精神病样体验、生活质量及其他药物使用天数(在6周和3、6、12个月的部分或全部时间点)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Australia has one of the highest rates of methamphetamine (MA) use in the world; however, uptake of in-person psychological treatment remains extremely low due to numerous individual (e.g. stigma, shame) and structural (e.g. service accessibility, geographical location) barriers to accessing care. Telephone-delivered interventions are ideally placed to overcome many of the known barriers to treatment access and delivery. This randomised controlled trial (RCT) will examine the efficacy of a standalone, structured telephone-delivered intervention to reduce MA problem severity and related harms. METHODS: This study is a double-blind, parallel-group RCT. We will recruit 196 ± 8 individuals with mild to moderate MA use disorder from across Australia. After eligibility and baseline assessments, participants will be randomly allocated to receive either the Ready2Change-Methamphetamine (R2C-M) intervention (n = 98 ± 4; four to six telephone-delivered intervention sessions, R2C-M workbooks and MA information booklet) or control (n = 98 ± 4; four to six ≤5-min telephone check-ins and MA information booklet including information on accessing further support). Telephone follow-up assessments will occur at 6 weeks and 3, 6 and 12 months post-randomisation. The primary outcome is change in MA problem severity (Drug Use Disorders Identification Test, DUDIT) at 3 months post-randomisation. Secondary outcomes are as follows: MA problem severity (DUDIT) at 6 and 12 months post-randomisation, amount of methamphetamine used, methamphetamine use days, methamphetamine use disorder criteria met, cravings, psychological functioning, psychotic-like experiences, quality of life and other drug use days (at some or all timepoints of 6 weeks and 3, 6 and 12 months post-randomisation). Mixed-methods program evaluation will be performed and cost-effectiveness will be examined. DISCUSSION: This study will be the first RCT internationally to assess the efficacy of a telephone-delivered intervention for MA use disorder and related harms. The proposed intervention is expected to provide an effective, low-cost, scalable treatment for individuals otherwise unlikely to seek care, preventing future harms and reducing health service and community costs. TRIAL REGISTRATION: ClinicalTrials.gov NCT04713124 . Pre-registered on 19 January 2021.
引用
- Lubman DI, Manning V, Arunogiri S, et al. A structured, telephone-delivered intervention to reduce methamphetamine use: study protocol for a parallel-group randomised controlled trial. Trials. 2023. PMID: 36991490. doi:10.1186/s13063-023-07172-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。